Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Prostatic Neoplasms 3Muscle Weakness 2Motor Activity 2Sedentary Behavior 1Sarcopenia 1Muscular Atrophy 1Head and Neck Neoplasms 1Fatigue 1Cachexia 1Body Weight Changes 1Anorexia 1

Interventions

Megestrol Acetate 11Mirtazapine 5Olanzapine 4anamorelin 2Infliximab 2nabiximols 1nabilone 1Watchful Waiting 1Thalidomide 1Surveys and Questionnaires 1Sugars 1Radiotherapy 1Quality of Life 1Palonosetron 1Observation 1Nicotine 1Modafinil 1Minocycline 1Melatonin 1Megestrol 1Magnetic Resonance Spectroscopy 1Gemcitabine 1Flurandrenolone 1Etanercept 1Eicosapentaenoic Acid 1EOM613 1Dronabinol 1Docetaxel 1Dexamethasone 1Creatine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Anorexia × Creatine × Clear all
NCT00081250 2020-04-29

Creatine in Treating Patients With Cancer-Associated Weight Loss

Alliance for Clinical Trials in Oncology

Phase 3 Completed
300 enrolled

Anorexia, Body Weight Changes, Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡